Mepolizumab/omalizumabLack of efficacy following off-label use

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 1998卷 / 1期

关键词：

D O I：

10.1007/s40278-024-54140-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：296 / 296

相关论文

共 50 条

[1] OmalizumabLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1956 (1) : 409 - 409
[2] OmalizumabLack of efficacy following off label use: 2 case reports
Reactions Weekly, 2022, 1909 (1) : 440 - 440
[3] ImmunosuppressantsLack of efficacy following off-label use
Reactions Weekly, 2024, 2016 (1) : 242 - 242
[4] TemozolomideLack of efficacy following off-label use
Reactions Weekly, 2024, 2002 (1) : 433 - 433
[5] PrednisoneLack of efficacy following off-label use
Reactions Weekly, 2024, 2005 (1) : 704 - 704
[6] DexamethasoneLack of efficacy following off-label use
Reactions Weekly, 2024, 2005 (1) : 303 - 303
[7] Mepolizumab/omalizumabInfusion reaction following an off-label use: 2 case reports
Reactions Weekly, 2019, 1766 (1) : 192 - 192
[8] ErenumabConstipation and lack of efficacy following off-label use
Reactions Weekly, 2024, 2013 (1) : 187 - 187
[9] VenetoclaxLack of efficacy following off-label use: case report
Reactions Weekly, 2025, 2041 (1) : 398 - 398
[10] DexamethasoneLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1887 (1) : 259 - 259

← 1 2 3 4 5 →